mantle cell lymphoma

Showing NaN - NaN of 17

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Waldenstrom Macroglobulinemia, Multiple Myeloma, Chronic Lymphocytic Leukemia Trial in Worldwide (Iopofosine I 131 single dose,

Recruiting
  • Waldenstrom Macroglobulinemia
  • +8 more
  • Iopofosine I 131 single dose
  • +2 more
  • Redlands, California
  • +42 more
Dec 30, 2022

CD20 Positive, Mantle Cell Lymphoma Trial in United States (procedure, other, biological)

Recruiting
  • CD20 Positive
  • Mantle Cell Lymphoma
  • Autologous Hematopoietic Stem Cell Transplantation
  • +2 more
  • Birmingham, Alabama
  • +318 more
Jan 3, 2023

CCND1 Positive, Mantle Cell Lymphoma, t(11;14) Positive Trial in Atlanta, Johns Creek (Bendamustine, Obinutuzumab, Venetoclax)

Active, not recruiting
  • CCND1 Positive
  • +2 more
  • Atlanta, Georgia
  • +2 more
Nov 2, 2022

A Disease Registry of Patients With Mantle Cell Lymphoma

Active, not recruiting
  • Mantle Cell Lymphoma
    • Montgomery, Alabama
    • +33 more
    Oct 28, 2022

    Melanoma, NSCLC, Breast Cancer Trial in United States (CDX-1140, CDX-301, Pembrolizumab)

    Completed
    • Melanoma
    • +25 more
    • Scottsdale, Arizona
    • +10 more
    Sep 27, 2022

    B-cell Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Mantle Cell Lymphoma Trial in United States (Cirmtuzumab (2-16

    Recruiting
    • B-cell Chronic Lymphocytic Leukemia
    • +3 more
    • Cirmtuzumab (2-16 kg/mg) plus Ibrutinib
    • +5 more
    • Duarte, California
    • +12 more
    Jun 16, 2022

    Collecting and Storing Tissue Samples From Rare or Cutaneous

    Active, not recruiting
    • Adult Immunoblastic Lymphoma
    • +12 more
    • Cytology Specimen Collection Procedure
    • Birmingham, Alabama
    • +129 more
    Mar 23, 2022

    Grade 1 Follicular Lymphoma, Grade 2 Follicular Lymphoma, Grade 3a Follicular Lymphoma Trial in Atlanta (drug, biological,

    Recruiting
    • Grade 1 Follicular Lymphoma
    • +7 more
    • Atlanta, Georgia
      Emory University Hospital/Winship Cancer Institute
    Dec 7, 2021

    Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, Burkitt's Lymphoma Trial in United States (Haploidentical Bone Marrow

    Completed
    • Acute Lymphocytic Leukemia
    • +6 more
    • Haploidentical Bone Marrow Transplant
    • Double Umbilical Cord Blood Transplant
    • Birmingham, Alabama
    • +38 more
    Nov 2, 2021

    Mantle Cell Lymphoma Trial in Atlanta (Ixazomib, Rituximab)

    Active, not recruiting
    • Mantle Cell Lymphoma
    • Atlanta, Georgia
    • +1 more
    Oct 26, 2021

    Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma Trial in Canada, United States (Entospletinib

    Terminated
    • Chronic Lymphocytic Leukemia
    • +4 more
    • Entospletinib MM
    • Entospletinib SDD
    • Birmingham, Alabama
    • +47 more
    Nov 2, 2020

    Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Aggressive Non-Hodgkin Lymphoma Trial in Denmark, Germany, United States

    Completed
    • Acute Lymphoblastic Leukemia
    • +18 more
    • Allogeneic Hematopoietic Stem Cell Transplantation
    • +6 more
    • Denver, Colorado
    • +10 more
    Oct 10, 2019

    Mantle Cell Lymphoma Trial in Worldwide (lenalidomide)

    Completed
    • Mantle Cell Lymphoma
    • Little Rock, Arkansas
    • +69 more
    Dec 11, 2018

    Acute Leukemia, Chronic Lymphocytic Leukemia, Chronic Myelogenous Leukemia, BCR-ABL1 Positive Trial in Atlanta (Thymoglobulin,

    Terminated
    • Acute Leukemia
    • +11 more
    • Thymoglobulin
    • +2 more
    • Atlanta, Georgia
      Emory University/Winship Cancer Institute
    Mar 30, 2018

    B-lymphoid Malignancies, Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma Trial in United States (SNS-032 Injection)

    Completed
    • B-lymphoid Malignancies
    • +3 more
    • SNS-032 Injection
    • Duarte, California
    • +5 more
    Apr 7, 2017

    Follicular Lymphoma, Diffuse Large Cell Lymphoma, Mantle Cell Lymphoma Trial in United States (AT-101)

    Completed
    • Follicular Lymphoma
    • +4 more
    • Birmingham, Alabama
    • +10 more
    Jun 24, 2011

    Mantle Cell Lymphoma Trial in United States (VELCADE TM (bortezomib) for Injection)

    Completed
    • Mantle Cell Lymphoma
    • VELCADE TM (bortezomib) for Injection
    • Birmingham, Alabama
    • +34 more
    Feb 7, 2008